Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuro Watanabe

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Cancer Cell|July 15, 2016
Context, Context, Context: New Gene Programs Linked to Bad Behavior in MLL-AF9-Initiated LeukemiaTatsuro Watanabe, Patricia Ernst
Journal of Cancer Research and Clinical Oncology|January 29, 2014
Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligandsHirota Fujiki, Tatsuro Watanabe, Masami Suganuma
Cancer Science|January 21, 2025
Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of DecitabineTatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
Archives of Microbiology|January 27, 2009
A small heat-shock protein confers stress tolerance and stabilizes thylakoid membrane proteins in cyanobacteria under oxidative stressKollimalai Sakthivel, Tatsuro Watanabe, Hitoshi Nakamoto
Journal of Cancer Research and Clinical Oncology|December 30, 2014
Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compoundsHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2018
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancersHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Journal of Cancer Prevention|April 9, 2015
Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compoundsHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Molecules and Cells|February 12, 2018
Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem CellsHirota Fujiki, Tatsuro Watanabe, Eisaburo Sueoka, et al.
Cancer Letters|March 31, 2012
Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pyloriMasami Suganuma, Tatsuro Watanabe, Kensei Yamaguchi, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2023
Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2AHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Cancer Cell|July 15, 2016
Context, Context, Context: New Gene Programs Linked to Bad Behavior in MLL-AF9-Initiated LeukemiaTatsuro Watanabe, Patricia Ernst
Journal of Cancer Research and Clinical Oncology|January 29, 2014
Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligandsHirota Fujiki, Tatsuro Watanabe, Masami Suganuma
Cancer Science|January 21, 2025
Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of DecitabineTatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
Archives of Microbiology|January 27, 2009
A small heat-shock protein confers stress tolerance and stabilizes thylakoid membrane proteins in cyanobacteria under oxidative stressKollimalai Sakthivel, Tatsuro Watanabe, Hitoshi Nakamoto
Journal of Cancer Research and Clinical Oncology|December 30, 2014
Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compoundsHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Journal of Cancer Research and Clinical Oncology|October 21, 2018
The concept of the okadaic acid class of tumor promoters is revived in endogenous protein inhibitors of protein phosphatase 2A, SET and CIP2A, in human cancersHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Journal of Cancer Prevention|April 9, 2015
Primary cancer prevention by green tea, and tertiary cancer prevention by the combination of green tea catechins and anticancer compoundsHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Molecules and Cells|February 12, 2018
Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem CellsHirota Fujiki, Tatsuro Watanabe, Eisaburo Sueoka, et al.
Cancer Letters|March 31, 2012
Human gastric cancer development with TNF-α-inducing protein secreted from Helicobacter pyloriMasami Suganuma, Tatsuro Watanabe, Kensei Yamaguchi, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2023
Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2AHirota Fujiki, Eisaburo Sueoka, Tatsuro Watanabe, et al.
Pageof 5